News
8h
News Letter on MSNNorthern Ireland biotech start up reimagining drug discovery through AI to accelerate life-saving therapiesAMPLY, the company behind the proprietary AMPLYfolioAI platform, is accelerating the discovery of new medicines for complex ...
Southern RNA is an Australian CDMO specialising in producing nucleic acid products that support the clinical development of ...
The Synthetic Biology Market is valued at USD 16.94 Billion in 2024 and is expected to reach USD 167.98 Billion by 2035 at a ...
One researchers explained that bacteria do a really, really good job of keeping the sequence you want and the sequence that you get.
1d
Clinical Trials Arena on MSNSynthetic control arms: full impact yet to be realisedMore than just a tool for advancing pipelines, trial efficiency is the name of the game when it comes to synthetic control arms.
Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.
SNS Insider Forecasts 13.29% CAGR from 2024 to 2032 as Demand Surges Across Pharma, Genomics, and AgricultureAustin, April 11, 2025 (GLOBE NEWSWIRE) -- Global Biotechnology Market Size & Growth ...
Biotechnology Reagents Market As per MRFR analysis, the Biotechnology Reagents Market Growth Size was estimated at 44.6 (USD Billion) in 20 ...
9h
Tech Xplore on MSNDNA sequencing at risk: Hackers could exploit genomic data vulnerabilitiesNext-generation DNA sequencing (NGS)—the same technology which is powering the development of tailor-made medicines, cancer ...
Gene syntax also affects the behavior of genetic circuits, and contributes to unpredictable outcomes in genetic networks.
In this webinar, Benoit Derrien will discuss new strategies using enzymatically synthesized DNA for gene construction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results